113 related articles for article (PubMed ID: 5158835)
1. Factors influencing the prognosis in myelomatosis.
Dawson AA; Ogston D
Postgrad Med J; 1971 Oct; 47(552):635-8. PubMed ID: 5158835
[TBL] [Abstract][Full Text] [Related]
2. Anaemia in patients with myelomatosis.
Ting WC; Cavill I; Jacobs A; Kaaba S; May A; Smith S; Whittaker JA
Br J Cancer; 1982 Jun; 45(6):887-94. PubMed ID: 7093123
[TBL] [Abstract][Full Text] [Related]
3. Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.
Br J Haematol; 1973 Jan; 24(1):123-39. PubMed ID: 4805842
[No Abstract] [Full Text] [Related]
4. Multiple-myeloma: review of 231 cases.
Advani SH; Soman CS; Talwalkar GV; Lyer YS; Bhatia HM
Indian J Cancer; 1978 Jun; 15(2):55-61. PubMed ID: 374240
[No Abstract] [Full Text] [Related]
5. Prognostic factors in multiple myeloma: a retrospective study using conventional statistical methods and a computer program.
Matzner Y; Benbassat J; Polliack A
Acta Haematol; 1978; 60(5):257-68. PubMed ID: 101012
[TBL] [Abstract][Full Text] [Related]
6. Monitoring myelomatosis.
Hobbs JR
Arch Intern Med; 1975 Jan; 135(1):125-30. PubMed ID: 1111461
[TBL] [Abstract][Full Text] [Related]
7. Factors of prognostic significance in myelomatosis.
Peto R
J Clin Pathol; 1972 Jun; 25(6):555. PubMed ID: 5043402
[No Abstract] [Full Text] [Related]
8. Prognostic features in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.
Br J Cancer; 1980 Dec; 42(6):831-40. PubMed ID: 7459218
[TBL] [Abstract][Full Text] [Related]
9. [Acute renal insufficiency in myelomatosis].
Ladefoged J; Nielsen B; Pedersen K
Ugeskr Laeger; 1970 Mar; 132(13):641-6. PubMed ID: 5426501
[No Abstract] [Full Text] [Related]
10. A progress report on the Medical Research Council's therapeutic trial in myelomatosis.
Galton DA; Peto R
Br J Haematol; 1968 Sep; 15(3):319-20. PubMed ID: 5696221
[No Abstract] [Full Text] [Related]
11. [Prognostic factors in the treatment of multiple myeloma].
Antipova LG
Ter Arkh; 1983; 55(8):59-63. PubMed ID: 6635958
[No Abstract] [Full Text] [Related]
12. High incidence of myelomatosis in North-East Scotland.
Dawson AA; Ogston D
Scott Med J; 1973 May; 18(3):75-7. PubMed ID: 4708559
[No Abstract] [Full Text] [Related]
13. Multiple myeloma. 2. A report on sixty-seven cases.
Hill RS; Wilson JD
N Z Med J; 1968 Feb; 67(428):194-203. PubMed ID: 5238829
[No Abstract] [Full Text] [Related]
14. [Prognosis in myelomatosis treated with prednisone and cytostatics].
Hansen OP; Jessen B; Videbaek A
Ugeskr Laeger; 1973 Jun; 135(23):1169-73. PubMed ID: 4757116
[No Abstract] [Full Text] [Related]
15. 61-Year-Old Man With Right Knee Pain and Chronic Anemia.
Binder M; Alkhateeb HB; Go RS
Mayo Clin Proc; 2016 Nov; 91(11):1640-1644. PubMed ID: 27499534
[No Abstract] [Full Text] [Related]
16. Myelomatosis: comparison of melphalan and cyclophosphamide therapy.
Br Med J; 1971 Mar; 1(5750):640-1. PubMed ID: 4926948
[TBL] [Abstract][Full Text] [Related]
17. Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis.
Goldschmidt N; Zamir L; Poperno A; Kahan NR; Paltiel O
J Am Board Fam Med; 2016 Nov; 29(6):702-709. PubMed ID: 28076253
[TBL] [Abstract][Full Text] [Related]
18. [Anemia in kidney diseases].
Karastanev I; Atanasov K
Urol Nefrol (Mosk); 1974; (6):17-9. PubMed ID: 4446179
[No Abstract] [Full Text] [Related]
19. Myeloma and leukaemia trials.
Peto R
Proc R Soc Med; 1972 Mar; 65(3):244-5. PubMed ID: 4563299
[No Abstract] [Full Text] [Related]
20. [Renal insufficiency in myelomatosis. Prognostic factors and survival].
Gregersen H; Ibsen JS; Nielsen M
Ugeskr Laeger; 1997 May; 159(22):3387-92. PubMed ID: 9199025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
